This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing new discoveries within Factor XI, like Anthos Therapeutics' abelacimab.
Ticker(s): REGN, NSVWho's the expert?
Institution: University of Utah
- Associate Professor in the Division of Hematology and Hematologic Malignancies at the University of Utah
- Research interest is focused on complications affecting patients with congenital bleeding disorders, specifically hemophilia patients with inhibitors
- Manages 40 patients with Hemophilia B
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
